Imperial College London

DrSandraNewton

Faculty of MedicineDepartment of Infectious Disease

Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7594 3191s.newton

 
 
//

Location

 

236Wright Fleming WingSt Mary's Campus

//

Summary

 

Collaborators

Professor Michael Levin, Professor Mark Nicol, Professor Heather Zar, Professor Gerhard Walz, Professor Beate Kampmann, Professor Tom Ottenhoff., National Institutes of Health (NIH) Grant (Imperial College London, University of Cape Town, University of Stellenbosch, MRC The Gambia at LSHTM, University of Leiden)., National Institute of Health (NIH) grant consortium - Validation of promising biomarkers for childhood tuberculosis and their development for future use as diagnostic tests., 2016 - 2021

Professor Håvard Jenssen, Roskilde University Denmark, Antimicrobial peptoids, 2016

Rachel Ee Pui Lai, National University of Singapore, 2011

Professor RA Floto, University of Cambridge, Tuberculosisnon tuberculous mycobacteriaAutophagyDrug screening, 2011

Michael Levin (PI), Imperial College London and EUCLIDS consortium, The genetic basis of meningococcal disease and other life threatening bacterial infections of childhood, 2011 - 2016

Paul Langford, Imperial College London, Antimicrobial polymers and nanoparticles, 2011 - 2012

Rachel Ee, Pui LaiNMRC grant, National University of Singapore,A Star University - Singapore, Active targeting of tuberculosis via novel nanotherapeutics, 2011 - 2014

Research Staff

Baumard,L

Powell,O

Wright,J

Research Student Supervision

Asai,M, Galleria mellonella: a novel infection model for Mycobacterium tuberculosis aimed at reducing and replacing animals in experimentation

Asai,M, MRes - Evaluation of de novo designed synthetic antimicrobial peptides for inhibitory growth activity of clinically relevant bacterial pathogens

Asai,M, Ph.D. Galleria mellonella - a novel infection model for Mycobacterium tuberculosis aimed at replacing the number of animals in experimentation.

Broderick,C, Ph.D. The role of viral coinfection in the progression of Mycobacterium tuberculosis infection in children

Chang,Y, MSc Development of a human in vitro granuloma model for rapid screening of anti-mycobacterial drugs

Cheyne,A, Ph.D. Applying –omics technology to understand host-pathogen interactions during Mycobacterium tuberculosis infection.

Claire,B, The role of viral coinfection in the progression of Mycobacterium tuberculosis infection

Curio,S, The evaluation of novel synthetic antimicrobial peptides for activity against non-tuberculous mycobacteria

Harris,K, MSc Assessment of a novel anti-mycobacterial agent in an in vitro kinetic model

Khara,JS, Ph.D. De novo design of antimicrobial peptides for application as anti--infective agents

Mansour,E, MSc An in vitro model of human mycobacterial-induced granulomas

Nkamba,HC, MSc Anti-mycobacterial activity and immunological responses of antimicrobial peptides

Sabnis,A, BSc Antimicrobial peptides: a novel therapeutic strategy against non-tuberculous mycobacteria infection?

Vijayakumar,P, BSc The effect of hydroxychloroquine on mycobacterial infection and growth

cheyne,A, Applying –omics technology to understand host-pathogen interactions during Mycobacterium tuberculosis infection using the whole-blood infection assay

von Both,U, ESPID Fellow: Childhood tuberculosis: A new acquired immunodeficiency syndrome.